Guardion Health Sciences, Inc. (GHSI) increased 94% to $1.86 and hit as high as $3.05 on Wednesday on over 30 million shares traded after announcing that its proprietary medical device, the MapcatSF®, received a patent from the Hong Kong Patents Registry. The patent was granted specifically for "Apparatus for Use in the Measurement of Macular Pigment Optical Density and/or Lens Optical Density of an Eye".
While a patent grant is always good news for a company, GHSI had hardly any reaction to the announcement of the exact same patent being granted for the